24 novembre 2024 : Rencontre en personne à Manchester, NH

Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event, hosted by AFTD Ambassador Shirley Gordon and Kevin Rhodes, co-chair of the AFTD Persons with FTD Advisory Council. The event will take place from 7:30 a.m. – 12:00 p.m. on November 24 at St. Catherine of Siena…

Lire la suite

In-Person Meet & Greet in Manchester, NH

Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event, hosted by AFTD Ambassador Shirley Gordon and Kevin Rhodes, co-chair of the AFTD Persons with FTD Advisory Council. RSVP for this event by emailing sgordon@theaftd.org. To learn more, download this flyer.

Lire la suite

Déjeuner-conférence pour soignants hybrides de l'Ohio : démence frontotemporale

Hybrid Caregiver Noontime Knowlege Series: Frontotemporal Dementia decorative image

Apportez votre lunch et rejoignez Judy Bearer, ambassadrice de l'Association for Frontotemporal Degeneration, pour ce déjeuner-causerie sur la dégénérescence frontotemporale (DFT), la cause la plus fréquente de démence chez les adultes de moins de 60 ans (même si elle peut frapper les adultes à tout âge). Nous passerons en revue les causes et symptômes possibles, trouverons des ressources locales et apprendrons comment…

Lire la suite

Webinaire AFTD : Diagnostic de l'aphasie progressive primaire

With primary progressive aphasia (PPA), problems with language and communication typically deteriorate gradually over time. Initial symptoms are sometimes attributed to anxiety or stress until the ongoing symptoms become disruptive enough to prompt further assessment by a specialist. This webinar is intended for clinicians to support early detection and accurate diagnosis of PPA.  Learners will…

Lire la suite

Faire avancer l'espoir : l'AFTD organise la table ronde de recherche FTD 2024

Text: AFTD Hosts 2024 Research Rountable Meeting Background: AFTD Staff and Board Members at the FTD Research Roundtable meeting.

The FTD Research Roundtable is an annual program designed to accelerate FTD drug development by convening various scientific stakeholders to identify common challenges and advance solutions for FTD clinical trials. Biopharmaceutical companies currently conducting FTD pre-clinical and clinical trials are invited to join the FTD Research Roundtable, and in 2024, we were thrilled to have…

Lire la suite

AC Immune et Life Molecular Imaging annoncent la désignation accélérée par la FDA pour le traceur Tau PET

Text: AC Immune and Life Molecular Imaging Announce FDA Fast Track Designation for Tau PET Tracer Background: A physician reviews PET scans on a tablet computer.

Swiss biopharmaceutical company AC Immune announced in late August that its partner, German biopharmaceutical company Life Molecular Imaging (LMI), received a Fast Track Designation from the US Food and Drug Administration (FDA) for a Tau PET tracer. PET, or positron emission tomography, is a form of medical imaging that uses a radioactive tracer to visualize…

Lire la suite

Emma Heming Willis partage son expérience de la FTD et son travail de plaidoyer dans le magazine « Town & Country »

Emma Heming Willis Town & Country interview decorative

Emma Heming Willis spoke with journalist Katie Couric about her journey as an FTD care partner, as well as her advocacy for FTD legislation and research following the diagnosis of her husband, Bruce Willis, in an interview published in the November 2024 issue of “Town & Country.” For her ongoing advocacy work, Mrs. Willis will be…

Lire la suite